Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions
Latest Information Update: 21 Dec 2023
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 18 Dec 2023 Status changed from active, no longer recruiting to completed.
- 28 Aug 2023 Phase has been removed and study design changed from open label to observational, cohort.
- 28 Aug 2023 Planned End Date changed from 1 Mar 2023 to 3 Oct 2023.